Dr. Colm Henry, Chief Clinical Officer and Sharon Hayden joined the meeting at 12.15pm.
The CCO provided an update on Covid, the Vaccination Programme, Therapeutics and the number of prescriptions notified between April and August both in the community and in the acute hospital setting. Dr. Henry advised that two sub-groups of the National Ukraine Health Response Planning and Coordination Group are being established to scope and design a sustainable future service model and advised that there are some public health concerns, particularly in relation to the risk of transmission of COVID in congregated settings, vaccination status and blood borne viruses. He also advised that a HSE Model of Care is being developed to incorporate additional care delivery domains.
The CCO advised that the WHO declared Monkeypox a public health emergency on 23rd July 2022 and that coordination of the integrated Health Protection MPX response from National Health Protection Acute Operations Response Programme and NHP Surveillance Programme/HPSC and NHP Immunisation Programme/NIO continues.
He reported that the identification of vaccine derived polio viruses has occurred in Europe and Northern America in 2022 and that this year, vaccine-type viruses were identified in the London waste-water system and that the Department of Health, in collaboration with national experts, developed a National Polio Plan (NPP) in 2011. He advised that the plan was updated in 2019 but requires further updates. He reported that the nation is 87.9% vaccinated, but that a higher level of vaccination is needed for herd immunity. The Committee held a discussion on the challenges caused by anti-vaccine propaganda and how to raise awareness of the issue.
The CCO provided an update on National Screening Services and advised that the Coombe Women and Infants University Hospital (CWIUH) have not processed cervical screening samples since the cyberattack. Extensive planning for the implementation of the Phase 1 Programme of the Cervical Check patient-requested review process is underway and will commence by year end and an interim report has been produced and is under revision by the Legal Framework Group. It was noted that the National Cervical Screening Laboratory project is developing a new bespoke laboratory designed for use as a national laboratory for cervical screening, which is due to be operational in Q4 2022.
Regarding the proposed amendment to the Patient Safety Bill by the Minister for Health, the CCO noted that correspondence has issued from the Chair of the Board to the Minister in regards to this matter. He also provided an update on Breastcheck and the Consultant Radiologist shortage and addressed the Termination of Pregnancy (TOP) data anomaly, where there was a discrepancy in the data reported by the media in early July. The CCO advised that where any un-submitted notifications are found, they will be forwarded to the Department, and an addendum to the Ministerial Report will be published.
The CCO reported that five adverse outcomes were reported to the OEST in August and that there have been seven maternal deaths since the start of 2021 to date. He advised that NWIHP have issued communications on ethnicity and suicide to the health system.
The CCO outlined the key findings from the “First Report into the Implementation of the Structured Chronic Disease Programme in GP practice” and will present on the key phases of the programme in a future meeting.
The CCO also provided an update on the reconfiguration of Our Lady’s Hospital Navan.
An update was provided with regards to Letterkenny University Hospital and also an update on Transgender Services as requested by the Chair. He advised that NHS England requested a recent review of Tavistock led by Professor Hilary Cass. The CCO and the clinical team are meeting Dr. Cass mid-September to discuss the report and findings. Dr. Orla Healy agreed to provide a report to the Committee in October, based on her engagement with Prof. Cass. The CCO also provided an update on National Service Plan priorities for 2023.